Close Menu


PATENT WATCH: Aug 17, 2001


Alpha Innotech, Rosetta Inpharmatics, Genetic Microsystems

Qiagen has signed on two new partners to its microarray efforts, making Bayer an early access customer for its ZeptoGene Workstation microarray platform, and acquiring exclusive distribution rights to Genicon Sciences self-spotted microarray toolkit products, the company said.

Semiconductor biochip startup CombiMatrix will see its microarrays launched into space in a deal with the National Aeronautics and Space Administration s Ames Research Center.

Motorola Life Sciences has moved forward in its bid to enter the high-density array business with the August 15 public launch of its Uniset Human I bioarray at the Drug Discovery Technology 2001 conference in Boston.

Agilent Technologies and Caliper Technologies have introduced the RNA 6000 Nano LabChip kit, an automated kit for quality control of RNA. The kit, which is designed for use with the Agilent 2100 bioanalyzer, was expected to begin shipping on August 15.

Fluidigm has appointed Douglas Modlin to the position of chief technology officer and vice president of research and development.

AT A GLANCE Ph.D. in biology from the University of Texas at Austin in 1984. Research interests center on using microarrays to examine microbes in the environment. Interests: Remodeling homes, reading.

Agilent Technologies and RNA producer Ambion have agreed to co-market several of their products, including the Agilent 2100 bioanalyzer, Agilent RNA LabChip kits, and Ambion s RNA-related reagents.

Corning quietly launched a human cancer gene array July 23, and has said it will launch its high-density human genome array by the end of the year.

Gene Logic spinoff Metrigenix has inked its first deal, saying it would work with central nervous system stem cell company Neuralstem to co-develop microarrays to study gene expression in the central nervous system.


Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.